Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p<0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both groups showed similar increases in the levels of alkaline phosphatase and comparable adjustments in antihypertensive therapy; blood pressure, however, did not change. CONCLUSION: The use of sibutramine caused weight loss and a reduction in left ventricular mass in obese and hypertensive patients with no interference with blood pressure or with antihypertensive therapy.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia - SBC
2002
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2002000200006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0066-782X2002000200006 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0066-782X20020002000062007-01-31Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial HypertensionFaria,Alessandra NunesRibeiro Filho,Fernando FlexaLerário,Daniel Diniz G.Kohlmann,NárciaFerreira,Sandra Roberta GouveaZanella,Maria Teresa sibutramine obesity arterial hypertension OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p<0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both groups showed similar increases in the levels of alkaline phosphatase and comparable adjustments in antihypertensive therapy; blood pressure, however, did not change. CONCLUSION: The use of sibutramine caused weight loss and a reduction in left ventricular mass in obese and hypertensive patients with no interference with blood pressure or with antihypertensive therapy.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.78 n.2 20022002-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2002000200006en10.1590/S0066-782X2002000200006 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Faria,Alessandra Nunes Ribeiro Filho,Fernando Flexa Lerário,Daniel Diniz G. Kohlmann,Nárcia Ferreira,Sandra Roberta Gouvea Zanella,Maria Teresa |
spellingShingle |
Faria,Alessandra Nunes Ribeiro Filho,Fernando Flexa Lerário,Daniel Diniz G. Kohlmann,Nárcia Ferreira,Sandra Roberta Gouvea Zanella,Maria Teresa Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
author_facet |
Faria,Alessandra Nunes Ribeiro Filho,Fernando Flexa Lerário,Daniel Diniz G. Kohlmann,Nárcia Ferreira,Sandra Roberta Gouvea Zanella,Maria Teresa |
author_sort |
Faria,Alessandra Nunes |
title |
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
title_short |
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
title_full |
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
title_fullStr |
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
title_full_unstemmed |
Effects of Sibutramine on the Treatment of Obesity in Patients with Arterial Hypertension |
title_sort |
effects of sibutramine on the treatment of obesity in patients with arterial hypertension |
description |
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p<0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both groups showed similar increases in the levels of alkaline phosphatase and comparable adjustments in antihypertensive therapy; blood pressure, however, did not change. CONCLUSION: The use of sibutramine caused weight loss and a reduction in left ventricular mass in obese and hypertensive patients with no interference with blood pressure or with antihypertensive therapy. |
publisher |
Sociedade Brasileira de Cardiologia - SBC |
publishDate |
2002 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2002000200006 |
work_keys_str_mv |
AT fariaalessandranunes effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension AT ribeirofilhofernandoflexa effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension AT lerariodanieldinizg effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension AT kohlmannnarcia effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension AT ferreirasandrarobertagouvea effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension AT zanellamariateresa effectsofsibutramineonthetreatmentofobesityinpatientswitharterialhypertension |
_version_ |
1756381454190772224 |